Last reviewed · How we verify

NCT05365139

Diagnostic Tools for Identifying Prolonged Grief

Completed Last updated 28 August 2025
What this trial tests

trial testing Structured clinical diagnostic interview for PGD (PGD-I) in Prolonged Grief Disorder in 124 participants. Completed in 1 November 2023.

Timeline
23 August 2021
Primary endpoint
1 November 2023
1 November 2023

Quick facts

Lead sponsorUniversity of Aarhus
StatusCompleted
Study typeOBSERVATIONAL
Enrollment124
Start date23 August 2021
Primary completion1 November 2023
Estimated completion1 November 2023
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

18 and older, any sex, with Prolonged Grief Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Development and validation of first clinical diagnostic interview for assessing Prolonged Grief Disorder (PGD) with the ICD 11 and DSM 5 Tr criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Prolonged Grief Disorder

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05365139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing